Jasper Therapeutics, Inc. · NASDAQ:JSPR

Goldman Sachs Group Inc reported a 6.30% stake in Jasper Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Feb 12, 2026

Goldman Sachs Group Inc reported a 6.30% stake in Jasper Therapeutics, Inc., 1,764,848 shares, as a passive investor on Dec 31, 2025. Filed Feb 12, 2026 (Schedule 13G).

Stake
6.30%
Shares
1,764,848
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
THE GOLDMAN SACHS GROUP, INC.6.30%1,764,848
GOLDMAN SACHS & CO. LLC6.30%1,764,848

Source

View original at SEC

Related